Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEssensys Regulatory News (ESYS)

Share Price Information for Essensys (ESYS)

Share Price is delayed by 15 minutes
Get Live Data
16.75    0.00 (0.00%)
Bid:
16.00
Ask:
17.50
Spread: 1.50 (9.375%)
Market Cap: £11.07m
ESYS Live PriceLast checked at - London Stock Exchange

Intraday Essensys Share Chart

Exercise of Options, Total Voting Rights - Replace

19 Mar 2026 16:54

RNS Number : 3772X
essensys PLC
19 March 2026
 

This announcement replaces RNS Number: 2042X as the total voting rights was incorrect. All other information was correct, and the full amended text is shown below.

 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD BE UNLAWFUL.

 

FOR IMMEDIATE RELEASE.

 

19 March 2026

 

essensys plc

Exercise of Options, Total Voting Rights & Rule 2.9 Announcement

 

essensys plc (AIM:ESYS) ("essensys", the "Company" and together with its subsidiary undertakings, the "Group"), the leading global provider of software and technology to the flexible workspace industry, announces that, following the exercise of employee share options, an application has been made for the admission of 44,690 new ordinary shares of 0.25 pence each ("Ordinary Shares") to trading on the AIM market of London Stock Exchange plc ("AIM"), with trading expected to occur on AIM at 8:00 a.m. on 20 March 2026 ("Admission").

 

The Company advises that, following Admission, its issued share capital will be 64,856,026 Ordinary Shares. The Company does not hold any Ordinary Shares in treasury. As such the Company's total number of Ordinary Shares with voting rights is 64,856,026.

 

The above figure of 64,856,026 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

 

In accordance with Rule 2.9 of the City Code on Takeovers and Mergers (the "Code"), essensys confirms that, as at the date and time of this announcement, its issued share capital consisted of 64,856,026 Ordinary Shares of 0.25 pence each which are admitted to trading on the AIM. The International Securities Identification Number for the Company's Ordinary Shares is GB00BJL1ZF49 and the Legal Entity Identifier is 2138002MSI4WKYNOBS73.

 

-Ends-

 

For further information, please contact:

essensys plc 

+44 (0)20 3102 5252

James Lowery, Chief Executive Officer 

Greg Price, Chief Financial Officer

 

Canaccord Genuity Limited (Nominated Adviser and Broker) 

+44 (0)20 7523 8000 

Simon Bridges / Harry Gooden / Andrew Potts / Elizabeth Halley-Stott

 

Gracechurch Group 

Heather Armstrong / Alexis Gore / Rebecca Scott

+44 (0) 20 4582 3500

essensys@gracechurchpr.com

 

About essensys plc 

essensys is the leading provider of software and technology to landlords and flexible workspace operators. Founded in 2006 and listed on the AIM market since 2019, essensys' mission is to power the world's largest community of flexible, technology-driven spaces. Under new leadership, the Company has simplified its go-to-market strategy around two core offerings: essensys Platform and elumo.

essensys Platform is a SaaS platform that delivers enterprise-grade Wi-Fi seamlessly across portfolios of multi-tenant workspaces, while providing data insights to optimise performance. The Group's latest offering, elumo, provides customers with a new way to manage and monetise bookable spaces. The integrated bookings and access solution transforms meeting rooms and shared spaces from operational headaches into revenue-generating assets.

With customers in the UK, Europe, North America and APAC, essensys is deploying a newly launched and simplified go-to-market strategy, positioning the business long-term growth in the flexible workspace and commercial real estate market.

Important notices

This announcement is not intended to, and does not, constitute or form part of any offer, invitation or the solicitation of an offer to purchase, otherwise acquire, subscribe for, sell or otherwise dispose of, any securities, or the solicitation of any vote or approval in any jurisdiction, pursuant to this announcement or otherwise.

The distribution of this announcement in jurisdictions outside the United Kingdom may be restricted by law and therefore persons into whose possession this announcement comes should inform themselves about, and observe, such restrictions. Any failure to comply with the restrictions may constitute a violation of the securities law of any such jurisdiction.

Canaccord Genuity Limited ("Canaccord Genuity"), which is authorised and regulated in the United Kingdom by the Financial Conduct Authority, is acting exclusively for essensys and for no-one else in connection with the matters referred to in this announcement and will not be responsible to any person other than essensys for providing the protections afforded to clients of Canaccord Genuity, nor for providing advice in relation to the matters referred to herein. Neither Canaccord Genuity nor any of its affiliates (nor any of its or their respective directors, officers, employees, representatives or agents) owes or accepts any duty, liability or responsibility whatsoever (whether direct or indirect, whether in contract, in tort, under statute or otherwise) to any person who is not a client of Canaccord Genuity in connection with the matters referred to in this announcement, or otherwise.

Disclosure requirements of the Code  

Under Rule 8.3(a) of the Code, any person who is interested in 1% or more of any class of relevant securities of an offeree company or of any securities exchange offeror (being any offeror other than an offeror in respect of which it has been announced that its offer is, or is likely to be, solely in cash) must make an Opening Position Disclosure following the commencement of the offer period and, if later, following the announcement in which any securities exchange offeror is first identified. An Opening Position Disclosure must contain details of the person's interests and short positions in, and rights to subscribe for, any relevant securities of each of (i) the offeree company and (ii) any securities exchange offeror(s). An Opening Position Disclosure by a person to whom Rule 8.3(a) applies must be made by no later than 3.30 pm (London time) on the 10th business day following the commencement of the offer period and, if appropriate, by no later than 3.30 pm (London time) on the 10th business day following the announcement in which any securities exchange offeror is first identified. Relevant persons who deal in the relevant securities of the offeree company or of a securities exchange offeror prior to the deadline for making an Opening Position Disclosure must instead make a Dealing Disclosure. 

Under Rule 8.3(b) of the Code, any person who is, or becomes, interested in 1% or more of any class of relevant securities of the offeree company or of any securities exchange offeror must make a Dealing Disclosure if the person deals in any relevant securities of the offeree company or of any securities exchange offeror. A Dealing Disclosure must contain details of the dealing concerned and of the person's interests and short positions in, and rights to subscribe for, any relevant securities of each of (i) the offeree company and (ii) any securities exchange offeror, save to the extent that these details have previously been disclosed under Rule 8. A Dealing Disclosure by a person to whom Rule 8.3(b) applies must be made by no later than 3.30 pm (London time) on the business day following the date of the relevant dealing. 

If two or more persons act together pursuant to an agreement or understanding, whether formal or informal, to acquire or control an interest in relevant securities of an offeree company or a securities exchange offeror, they will be deemed to be a single person for the purpose of Rule 8.3. 

Opening Position Disclosures must also be made by the offeree company and by any offeror and Dealing Disclosures must also be made by the offeree company, by any offeror and by any persons acting in concert with any of them (see Rules 8.1, 8.2 and 8.4). Details of the offeree and offeror companies in respect of whose relevant securities Opening Position Disclosures and Dealing Disclosures must be made can be found in the Disclosure Table on the Takeover Panel's website at www.thetakeoverpanel.org.uk, including details of the number of relevant securities in issue, when the offer period commenced and when any offeror was first identified. You should contact the Panel's Market Surveillance Unit on +44 (0)20 7638 0129 if you are in any doubt as to whether you are required to make an Opening Position Disclosure or a Dealing Disclosure. 

The defined terms used in this section "Disclosure requirements of the Code" are defined in the Code which can be found on the Takeover Panel's website.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEAKCBQABKDFND
Date   Source Headline
1st Jun 202612:27 pmRNSResult of General Meeting
29th May 20262:26 pmRNSHolding(s) in Company
14th May 20267:00 amRNSPosting of circular and notice of general meeting
14th May 20267:00 amRNSCompulsory Acquisition and Closure of Offer
11th May 20266:11 pmRNSHolding(s) in Company
11th May 20267:00 amRNSProposed cancellation of admission to trading
8th May 20266:00 pmRNSEssensys
8th May 20265:38 pmRNSExercise of Options and Total Voting Rights
8th May 20267:45 amRNSDisclosure Table
8th May 20267:00 amRNSOffer Declared Unconditional
7th May 20261:18 pmRNSForm 8.3 - Essensys Plc
7th May 20268:51 amRNSForm 8.5 (EPT/RI)
7th May 20267:00 amRNSDay 58 Acceptance Level Update
6th May 20267:00 amRNSDay 57 Acceptance Level Update
5th May 20267:00 amRNSDay 56 acceptance level update
30th Apr 202611:04 amRNSForm 8.3 - Essensys Plc
30th Apr 20269:55 amRNSForm 8.5 (EPT/RI)
28th Apr 20264:13 pmRNSForm 8.3 - Essensys PLC
28th Apr 20267:00 amRNSAcceptance Level Update
22nd Apr 202611:14 amRNSForm 8.3 - Essensys Plc
22nd Apr 202610:26 amRNSForm 8.5 (EPT/RI)
21st Apr 202611:36 amRNSForm 8.3 - Essensys PLC
21st Apr 202610:41 amRNSForm 8.5 (EPT/RI)
21st Apr 20267:00 amRNSDay 42 acceptance level update
17th Apr 202611:36 amRNSForm 8.3 - Essensys Plc
17th Apr 20267:00 amRNSHalf year results
14th Apr 20267:00 amRNSDay 35 acceptance level update
7th Apr 20267:00 amRNSDay 28 Acceptance Level Update
31st Mar 20267:00 amRNSDay 21 Acceptance Level Update
30th Mar 202612:15 pmRNSForm 8.3 - Essensys Plc
23rd Mar 20261:07 pmRNSForm 8.3 - Essensys Plc
19th Mar 20264:54 pmRNSExercise of Options, Total Voting Rights - Replace
18th Mar 20265:04 pmRNSExercise of Options, Total Voting Rights
11th Mar 202610:55 amRNSForm 8.3 - Essensys Plc
9th Mar 20263:35 pmRNSPublication of Offer Document
4th Mar 20261:48 pmRNSForm 8.3 - Essensys PLC
3rd Mar 20266:01 pmRNSForm 8.3 - Essensys plc
2nd Mar 20265:16 pmRNSForm 8.3 - essensys PLC
2nd Mar 20263:07 pmRNSForm 8.3 - Essensys plc
2nd Mar 20262:09 pmRNSForm 8.3 - Essenys Group Ltd
2nd Mar 202610:23 amRNSForm 8.5 (EPT/RI)
27th Feb 20265:54 pmRNSForm 8.3 - Essensys Plc
27th Feb 20265:24 pmRNSHolding(s) in Company
27th Feb 20263:54 pmRNSForm 8.3 - essensys plc
26th Feb 20262:54 pmRNSForm 8.3 - Essenys PLC
26th Feb 202612:30 pmRNSForm 8.3 - essensys plc
26th Feb 202611:35 amRNSForm 8.3 - ESSENSYS
26th Feb 202610:16 amRNSForm 8.5 (EPT/RI)
25th Feb 20264:13 pmRNSForm 8.3 - Essensys plc
25th Feb 20262:55 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.